Association of human papillomavirus with vulvar and vaginal intraepithelial disease: Opportunities for prevention

Matt Pearson, Richard S. Feltman, Leo B. Twiggs

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

While the majority of studies regarding the health benefits from human papillomavirus (HPV) vaccination have focused on cervical neoplasia and cancer, few have investigated how the epidemiology of vaginal and vulvar disease may be affected. To better understand how occurrence rates for vaginal and vulvar neoplasias and carcinomas may change in the future, we must have an understanding of the overall disease prevalence within a given population, the efficacy of vaccination and the proportion of cases attributable to HPV types administered in the vaccine. In this review, we will examine basic HPV epidemiology and prevalence, the molecular transformation events carried out by HPV oncoproteins, and clinical trials monitoring HPV-induced disease of the female genital tract. While precise projections of exactly how vaginal and vulvar disease prevalence will change with vaccination will require more studies, the preliminary data are promising.

Original languageEnglish
Pages (from-to)143-150
Number of pages8
JournalWomen's Health
Volume4
Issue number2
DOIs
StatePublished - Mar 1 2008

Fingerprint

Vaginal Diseases
Vulvar Diseases
Vaccination
Female Genital Diseases
Molecular Epidemiology
Oncogene Proteins
Insurance Benefits
Uterine Cervical Neoplasms
Neoplasms
Epidemiology
Vaccines
Clinical Trials
Carcinoma
Population

Keywords

  • Cancer
  • HPV
  • Vaccine
  • Vagina
  • Vulva

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Association of human papillomavirus with vulvar and vaginal intraepithelial disease : Opportunities for prevention. / Pearson, Matt; Feltman, Richard S.; Twiggs, Leo B.

In: Women's Health, Vol. 4, No. 2, 01.03.2008, p. 143-150.

Research output: Contribution to journalArticle

@article{61d1236889804121ac7515fc44029fb3,
title = "Association of human papillomavirus with vulvar and vaginal intraepithelial disease: Opportunities for prevention",
abstract = "While the majority of studies regarding the health benefits from human papillomavirus (HPV) vaccination have focused on cervical neoplasia and cancer, few have investigated how the epidemiology of vaginal and vulvar disease may be affected. To better understand how occurrence rates for vaginal and vulvar neoplasias and carcinomas may change in the future, we must have an understanding of the overall disease prevalence within a given population, the efficacy of vaccination and the proportion of cases attributable to HPV types administered in the vaccine. In this review, we will examine basic HPV epidemiology and prevalence, the molecular transformation events carried out by HPV oncoproteins, and clinical trials monitoring HPV-induced disease of the female genital tract. While precise projections of exactly how vaginal and vulvar disease prevalence will change with vaccination will require more studies, the preliminary data are promising.",
keywords = "Cancer, HPV, Vaccine, Vagina, Vulva",
author = "Matt Pearson and Feltman, {Richard S.} and Twiggs, {Leo B.}",
year = "2008",
month = "3",
day = "1",
doi = "10.2217/17455057.4.2.143",
language = "English",
volume = "4",
pages = "143--150",
journal = "Women's health (London, England)",
issn = "1745-5065",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Association of human papillomavirus with vulvar and vaginal intraepithelial disease

T2 - Opportunities for prevention

AU - Pearson, Matt

AU - Feltman, Richard S.

AU - Twiggs, Leo B.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - While the majority of studies regarding the health benefits from human papillomavirus (HPV) vaccination have focused on cervical neoplasia and cancer, few have investigated how the epidemiology of vaginal and vulvar disease may be affected. To better understand how occurrence rates for vaginal and vulvar neoplasias and carcinomas may change in the future, we must have an understanding of the overall disease prevalence within a given population, the efficacy of vaccination and the proportion of cases attributable to HPV types administered in the vaccine. In this review, we will examine basic HPV epidemiology and prevalence, the molecular transformation events carried out by HPV oncoproteins, and clinical trials monitoring HPV-induced disease of the female genital tract. While precise projections of exactly how vaginal and vulvar disease prevalence will change with vaccination will require more studies, the preliminary data are promising.

AB - While the majority of studies regarding the health benefits from human papillomavirus (HPV) vaccination have focused on cervical neoplasia and cancer, few have investigated how the epidemiology of vaginal and vulvar disease may be affected. To better understand how occurrence rates for vaginal and vulvar neoplasias and carcinomas may change in the future, we must have an understanding of the overall disease prevalence within a given population, the efficacy of vaccination and the proportion of cases attributable to HPV types administered in the vaccine. In this review, we will examine basic HPV epidemiology and prevalence, the molecular transformation events carried out by HPV oncoproteins, and clinical trials monitoring HPV-induced disease of the female genital tract. While precise projections of exactly how vaginal and vulvar disease prevalence will change with vaccination will require more studies, the preliminary data are promising.

KW - Cancer

KW - HPV

KW - Vaccine

KW - Vagina

KW - Vulva

UR - http://www.scopus.com/inward/record.url?scp=41949112805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949112805&partnerID=8YFLogxK

U2 - 10.2217/17455057.4.2.143

DO - 10.2217/17455057.4.2.143

M3 - Article

C2 - 19072516

AN - SCOPUS:41949112805

VL - 4

SP - 143

EP - 150

JO - Women's health (London, England)

JF - Women's health (London, England)

SN - 1745-5065

IS - 2

ER -